Pfizer’s US Rituximab Launched At A 24% Discount

Trastuzumab Will Launch Next Month With A 22% Lower Price

 
• By David Wallace
  
Hands_Rockets
Pfizer will be the first firm to launch three oncology monoclonal antibody US biosimilars • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin